A patient suffering with severe asthma (accompanied with allergic oculorhinitis), which, despite multidrug therapy and oral steroids (with consequent osteoporosis), was anyway obliged to several hospitalisations and rescues. Omalizumab was added-on and used during several months without appreciable results. Its therapeutic activity appeared only after eighth months of treatment, following this time only giving rise to clinical and functional improvement and better quality of life. The possibility of apparent "non responders" (in the facts "late responders") to omalizumab has to be taken into the highest consideration.
|Translated title of the contribution||Late response to Omalizumabin a patient with severe persistent allergic asthma|
|Number of pages||3|
|Journal||GIMT - Giornale Italiano delle Malattie del Torace|
|Publication status||Published - 2006|
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine